rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
16
|
pubmed:dateCreated |
2005-10-17
|
pubmed:abstractText |
Despite a growing emphasis worldwide on complex and potent antiretroviral drug regimens for the prevention of mother-to-child transmission of HIV-1 (MTCT), two-dose nevirapine (NVP) prophylaxis remains an important choice in many settings. We analyzed data from a multicenter clinical trial to determine whether timing of maternal or infant NVP was associated with MTCT between delivery and 6 weeks of age (intrapartum/early postnatal transmission; I/EP).
|
pubmed:grant |
|
pubmed:commentsCorrections |
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Nov
|
pubmed:issn |
0269-9370
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:day |
4
|
pubmed:volume |
19
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
1857-64
|
pubmed:dateRevised |
2008-11-21
|
pubmed:meshHeading |
pubmed-meshheading:16227794-Anti-HIV Agents,
pubmed-meshheading:16227794-Double-Blind Method,
pubmed-meshheading:16227794-Drug Administration Schedule,
pubmed-meshheading:16227794-Female,
pubmed-meshheading:16227794-HIV Infections,
pubmed-meshheading:16227794-Humans,
pubmed-meshheading:16227794-Infant,
pubmed-meshheading:16227794-Infant, Newborn,
pubmed-meshheading:16227794-Infectious Disease Transmission, Vertical,
pubmed-meshheading:16227794-Nevirapine,
pubmed-meshheading:16227794-Pregnancy,
pubmed-meshheading:16227794-Pregnancy Complications, Infectious,
pubmed-meshheading:16227794-Risk Factors,
pubmed-meshheading:16227794-Self Administration,
pubmed-meshheading:16227794-Time Factors
|
pubmed:year |
2005
|
pubmed:articleTitle |
Timing of maternal and neonatal dosing of nevirapine and the risk of mother-to-child transmission of HIV-1: HIVNET 024.
|
pubmed:affiliation |
University of Alabama at Birmingham, Department of Obstetrics & Gynecology, Birmingham, Alabama, USA. bchi@cidrz.org
|
pubmed:publicationType |
Journal Article,
Comparative Study,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't,
Multicenter Study,
Research Support, N.I.H., Extramural
|